To evaluate if Spry3 is expressed in cancer cells originating from different tissues, we first compared Spry3 expression in cell lines derived from lung, bone, colon and breast tumors with the levels observed in brain cancer-derived cell lines. This evidence concerns the gene SPRY3 and breast neoplasm.